Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cell Death & Disease|October 13, 2021
Stat1 confers sensitivity to radiation in cervical cancer cells by controlling Parp1 levels: a new perspective for Parp1 inhibitionGiuseppina Raspaglio, Marianna Buttarelli, Flavia Filippetti, et al.
Gynecologic Oncology|May 23, 2018
Estrogen receptor β: Potential target for therapy in adult granulosa cell tumors?Alessandra Ciucci, Gabriella Ferrandina, Floriana Mascilini, et al.
Oncology Research|December 15, 2010
RON and cisplatin resistance in ovarian cancer cell linesSilvia Prislei, Marisa Mariani, Giuseppina Raspaglio, et al.
Gynecologic Oncology|May 13, 2017
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancerMarta De Donato, Marco Petrillo, Enrica Martinelli, et al.
Molecular Cancer Therapeutics|January 12, 2008
From plasma membrane to cytoskeleton: a novel function for semaphorin 6ASilvia Prislei, Simona Mozzetti, Flavia Filippetti, et al.
Cancer Research|March 23, 2005
The seco-taxane IDN5390 is able to target class III beta-tubulin and to overcome paclitaxel resistanceCristiano Ferlini, Giuseppina Raspaglio, Simona Mozzetti, et al.
Molecular Cancer Therapeutics|July 23, 2008
Proteomic characterization of cytoskeletal and mitochondrial class III beta-tubulinLucia Cicchillitti, Roberta Penci, Michela Di Michele, et al.
Gynecologic Oncology|February 24, 2017
Hormone receptor expression profile of low-grade serous ovarian cancersMarianna Buttarelli, Floriana Mascilini, Gian Franco Zannoni, et al.
Biochemical Pharmacology|September 12, 2012
Gli family transcription factors are drivers of patupilone resistance in ovarian cancerSimona Mozzetti, Enrica Martinelli, Giuseppina Raspaglio, et al.
Gene|January 8, 2008
Hypoxia induces class III beta-tubulin gene expression by HIF-1alpha binding to its 3' flanking regionGiuseppina Raspaglio, Flavia Filippetti, Silvia Prislei, et al.
Pageof 2